Captopril, a sulfhydryl-containing dipeptide analog that acts as a potent Angiotensin-Converting Enzyme (ACE) inhibitor that may impact tumor vasculature and immune modulation [41], is titrated to 50 mg twice daily. Here, ACE is linked to neoplasm.